Cargando…

Correction to: MINDY1 promotes breast cancer cell proliferation by stabilizing estrogen receptor α

Detalles Bibliográficos
Autores principales:	Tang, Jianing, Luo, Yongwen, Long, Guo, Zhou, Ledu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795152/ https://www.ncbi.nlm.nih.gov/pubmed/35087032 http://dx.doi.org/10.1038/s41419-022-04549-7

Ejemplares similares

MINDY1 promotes breast cancer cell proliferation by stabilizing estrogen receptor α
por: Tang, Jianing, et al.
Publicado: (2021)

MINDY1 promotes bladder cancer progression by stabilizing YAP
por: Luo, Yongwen, et al.
Publicado: (2021)

TRIM11 promotes breast cancer cell proliferation by stabilizing estrogen receptor α
por: Tang, Jianing, et al.
Publicado: (2020)

OTUD7B stabilizes estrogen receptor α and promotes breast cancer cell proliferation
por: Tang, Jianing, et al.
Publicado: (2021)

Correction: The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation
por: Zhu, J., et al.
Publicado: (2018)

Mechanism of activation and regulation of deubiquitinase activity in MINDY1 and MINDY2
por: Abdul Rehman, Syed Arif, et al.
Publicado: (2021)

SHARPIN stabilizes estrogen receptor α and promotes breast cancer cell proliferation
por: Zhuang, Ting, et al.
Publicado: (2017)

Stabilization of estrogen receptor α by USP37 contributes to the progression of breast cancer
por: Cao, Jing, et al.
Publicado: (2023)

Genome Sequence of Mycobacteriophage Mindy
por: Pope, Welkin H., et al.
Publicado: (2015)

Correction: Xenoestrogens Alter Estrogen Receptor (ER) α Intracellular Levels
Publicado: (2014)

Correction: Estrogen Receptor β2 Induces Hypoxia Signature of Gene Expression by Stabilizing HIF-1α in Prostate Cancer
por: Dey, Prasenjit, et al.
Publicado: (2015)

MINdI: Mindfulness Instruction for New Interns
por: Cheston, Christine C., et al.
Publicado: (2020)

USP26 promotes anaplastic thyroid cancer progression by stabilizing TAZ
por: Tang, Jianing, et al.
Publicado: (2022)

Regulation of ERα Stability and Estrogen Signaling in Breast Cancer by HOIL-1
por: Ding, Jianing, et al.
Publicado: (2021)

Correction: Antineoplastic Effects of α-Santalol on Estrogen Receptor-Positive and Estrogen Receptor-Negative Breast Cancer Cells through Cell Cycle Arrest at G2/M Phase and Induction of Apoptosis
por: Santha, Sreevidya, et al.
Publicado: (2013)

The deubiquitinase EIF3H promotes hepatocellular carcinoma progression by stabilizing OGT and inhibiting ferroptosis
por: Tang, Jianing, et al.
Publicado: (2023)

Identification of Post-Transcriptional Modulators of Breast Cancer Transcription Factor Activity Using MINDy
por: Campbell, Thomas M., et al.
Publicado: (2016)

The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation
por: Zhu, J, et al.
Publicado: (2014)

USP8 positively regulates hepatocellular carcinoma tumorigenesis and confers ferroptosis resistance through β-catenin stabilization
por: Tang, Jianing, et al.
Publicado: (2023)

USP35, regulated by estrogen and AKT, promotes breast tumorigenesis by stabilizing and enhancing transcriptional activity of estrogen receptor α
por: Cao, Jiawei, et al.
Publicado: (2021)

Correction: Estrogen Signalling and the Metabolic Syndrome: Targeting the Hepatic Estrogen Receptor Alpha Action
por: Matic, Marko, et al.
Publicado: (2019)

The deubiquitinating enzyme MINDY2 promotes pancreatic cancer proliferation and metastasis by stabilizing ACTN4 expression and activating the PI3K/AKT/mTOR signaling pathway
por: Liu, Peng, et al.
Publicado: (2023)

Correction to: Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy
por: Wardell, Suzanne E., et al.
Publicado: (2019)

Correction: Decline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin
por: Colditz, Graham A
Publicado: (2007)

Correction: Estrogen-dependent downregulation of hypoxia-inducible factor (HIF)-2α in invasive breast cancer cells
por: Fuady, Jerry H., et al.
Publicado: (2017)

Correction: Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status
por: Di Leva, Gianpiero, et al.
Publicado: (2013)

Correction: A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation
por: Brekman, Angelika, et al.
Publicado: (2012)

Ring finger protein 6 promotes breast cancer cell proliferation by stabilizing estrogen receptor alpha
por: Zeng, Yuanying, et al.
Publicado: (2017)

ERα-LBD, an isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistance
por: Strillacci, Antonio, et al.
Publicado: (2022)

Correction: Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1
por: Neubauer, Hans, et al.
Publicado: (2009)

Correction to: Observational study on the prognostic value of testosterone and adiposity in postmenopausal estrogen receptor positive breast cancer patients
por: Venturelli, Elisabetta, et al.
Publicado: (2018)

The Peculiar Estrogenicity of Diethyl Phthalate: Modulation of Estrogen Receptor α Activities in the Proliferation of Breast Cancer Cells
por: Fiocchetti, Marco, et al.
Publicado: (2021)

Correction: Identification of Modulators of the Nuclear Receptor Peroxisome Proliferator-Activated Receptor α (PPARα) in a Mouse Liver Gene Expression Compendium
Publicado: (2015)

Targeting USP8 Inhibits O‐GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT
por: Tang, Jianing, et al.
Publicado: (2023)

Publisher Correction: Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models
por: Michmerhuizen, Anna R., et al.
Publicado: (2022)

Correction to: TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast Cancer
Publicado: (2023)

Correction: OTUB2 regulates KRT80 stability via deubiquitination and promotes tumour proliferation in gastric cancer
por: Ouyang, Siwen, et al.
Publicado: (2022)

AGR3 promotes estrogen receptor-positive breast cancer cell proliferation in an estrogen-dependent manner
por: Jian, Lei, et al.
Publicado: (2020)

Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
por: Bianco, Gaia, et al.
Publicado: (2022)

Correction: Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy
por: Munzone, Elisabetta, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_h6b4so908v88qss5k2s6r4e7rv